Matt helps developers and innovators in the healthcare industry protect their ideas through patent strategies and dispute resolution.
Matt, as a registered patent attorney and intellectual property litigator, advocates for clients in patent litigation and post-grant proceedings, including litigation arising under the Hatch-Waxman Act. In addition to his litigation and post-grant practice, Matt has extensive experience developing global patent prosecution strategies, drafting legal opinions and licensing agreements, and performing patentability and freedom-to-operate analyses. Matt has experience in numerous biotechnological areas, including but not limited to:
- Pharmaceuticals & biologics
- Chemotherapeutics (both large and small molecule)
- Antibodies and derivatives thereof
- Cell-based therapeutics (including CAR-T cells)
- Host cells, genetic vectors and vaccines
- Recombinants
- Methods related to the purification and production of target proteins
- DNA and RNA cloning and amplification techniques
- Medical devices
Clients value Matt’s prior experience as patent counsel in the oncology division of one of the world's leading biopharmaceutical companies, where he oversaw and developed the patent estates of oncology pipeline biologics. In addition to his legal practice, Matt earned his M.S. in Medical Cannabis Sciences and Therapeutics, developing a heightened understanding of the scientific and clinical uses of the cannabis plant to augment his legal perspectives on cannabis-related issues.